Nonviral vector-mediated thymidine kinase gene transfer and ganciclovir treatment in leiomyoma cells

Objective To test the hypotheses that ganciclovir is cytotoxic to leiomyoma cells transfected with herpes simplex virus thymidine kinase and that estrogen modulates the responsiveness of tumor cells to this gene therapy approach. Methods Human and rat cultured uterine leiomyoma cells were transfected with plasmids encoding the β-galactosidase gene, thymidine kinase gene, or a control plasmid. Transfection efficiency was monitored by measuring β-galactosidase enzyme activity. Ganciclovir cytotoxicity in thy midine kinase-transfected cells was assessed by monitoring cell viability using trypan blue exclusion. The “bystander effect,” a phenomenon in which thymidine kinaseexpressing cells exposed to ganciclovir are toxic to adjacent thymidine kinase-nonexpressing cells, was assessed when thymidine kinase vector-transfected cells were cocultured with control plasmid-transfected cells at various percentages before exposure to ganciclovir. The effect of estradiol on ganciclovir-thymidine kinase-mediated cytotoxicity was assessed in estrogen-responsive rat leiomyoma cells. Results A thymidine kinase-ganciclovir-mediated “bystander effect” was demonstrated, with 48.6% (human) and 65.6% (rat) cell death when 5% of the leiomyoma cells were transfected with the pNGVL1-tk vector, with 0.84% and 1.9% of the cells expected to express thymidine kinase as based on the 16.7% and 39.8% transfection efficiency determined by the reporter gene assay in human and rat leiomyoma cells, respectively. Estradiol promoted cell growth and enhanced the “bystander effect” in rat leiomyoma cells. Conclusion These findings demonstrate the feasibility of using thymidine kinase gene therapy as a novel treatment for uterine leiomyomas. The effect of estrogen may provide a mechanism to enhance the tumor-suppressive effect of this approach.